Intuitive Surgical Stock Surges 27%, With A 5-Day Winning Spree
Intuitive Surgical (ISRG) stock hit day 5 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 27% return. The company has gained about $42 Bil in value over the last 5 days, with its current market capitalization at about $197 Bil. The stock remains 5.6% above its value at the end of 2024. This compares with year-to-date returns of 14.6% for the S&P 500.
ISRG provides innovative surgical systems that empower physicians to perform complex minimally invasive procedures, improving quality and access to healthcare worldwide. After this rally, is ISRG still a buy – or is it time to lock in gains? Deep dive with Buy or Sell ISRG.
A single stock can be risky, but there is a huge value to a broader, diversified approach we take with the Trefis High Quality Portfolio. That is one way to look at stocks. The Trefis High Quality Portfolio evaluates much more, and is designed to reduce stock-specific risk while giving upside exposure.
Comparing ISRG Stock Returns With The S&P 500
- Why PODD Could Outperform Intuitive Surgical Stock
- Intuitive Surgical Stock Now 16% Cheaper, Time To Buy
- Intuitive Surgical Stock Pulls Back to Support – Smart Entry?
- Intuitive Surgical Stock Now 12% Cheaper, Time To Buy
- Better Value & Growth: PODD Leads Intuitive Surgical Stock
- Intuitive Surgical Stock: Join the Rally at a 11% Discount
The following table summarizes the return for ISRG stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | ISRG | S&P 500 |
|---|---|---|
| 1D | 4.6% | 0.6% |
| 5D (Current Streak) | 26.8% | 1.6% |
| 1M (21D) | 24.2% | 1.5% |
| 3M (63D) | 11.2% | 5.5% |
| YTD 2025 | 5.6% | 14.6% |
| 2024 | 54.7% | 23.3% |
| 2023 | 27.1% | 24.2% |
| 2022 | -26.1% | -19.4% |
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. However, big gains can follow sharp reversals – but how has ISRG behaved after prior drops? See ISRG Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 42 S&P constituents with 3 days or more of consecutive gains and 35 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 8 | 27 |
| 4D | 8 | 6 |
| 5D | 17 | 1 |
| 6D | 5 | 1 |
| 7D or more | 4 | 0 |
| Total >=3 D | 42 | 35 |
Key Financials for Intuitive Surgical (ISRG)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $7.1 Bil | $8.4 Bil |
| Operating Income | $1.8 Bil | $2.3 Bil |
| Net Income | $1.8 Bil | $2.3 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $2.4 Bil | $2.5 Bil |
| Operating Income | $743.4 Mil | $759.7 Mil |
| Net Income | $658.4 Mil | $704.4 Mil |
While ISRG stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.